Highlights and Quick Summary
- Free Cash Flow Growth for the quarter ending June 30, 2021 was -57.91% (a -169.12% decrease compared to previous quarter)
- Year-over-year quarterly Free Cash Flow Growth decreased by -88.78%
- Annual Free Cash Flow Growth for 2021 was 11.69% (a -98.68% decrease from previous year)
- Annual Free Cash Flow Growth for 2021 was 884.68% (a 64950.0% increase from previous year)
- Annual Free Cash Flow Growth for 2020 was 1.36% (a -98.48% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Free Cash Flow Growth of Biofrontera AG Sponsored ADR
Most recent Free Cash Flow Growthof BFAGY including historical data for past 10 years.Interactive Chart of Free Cash Flow Growth of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Free Cash Flow Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | -57.91% | 11.69% |
| 2020 | – | – | – | 83.78% | 1.36% |
| 2019 | – | – | – | – | -0.63% |
| 2018 | – | – | – | – | 2.15% |
| 2017 | – | – | – | 36.67% | -5.73% |
| 2016 | -516.35% | – | – | – | 5.77% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic